Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
Go back to Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine| Pfizer Inc. (NYSE: PFE) | Delayed: 26.17 --26.17 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $37.39 | |||
| Open | $26.17 | 52 Week Low | $28.25 | |||
| Day High | $26.17 | P/E | 15.86 | |||
| Day Low | $26.17 | EPS | $1.65 | |||
| Volume | 39,960 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.17 --26.17 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $37.39 | |||
| Open | $26.17 | 52 Week Low | $28.25 | |||
| Day High | $26.17 | P/E | 15.86 | |||
| Day Low | $26.17 | EPS | $1.65 | |||
| Volume | 39,960 | |||||

